Search

Your search keyword '"Formoso, G"' showing total 208 results

Search Constraints

Start Over You searched for: Author "Formoso, G" Remove constraint Author: "Formoso, G"
208 results on '"Formoso, G"'

Search Results

2. Epigenetically-driven persistence of inflammatory and oxidative phenotypes in adolescents born to women with gestational diabetes

3. Short-term effectiveness of dapagliflozin versus DPP-4 inhibitors in elderly patients with type 2 diabetes: a multicentre retrospective study

5. Predictors of early discontinuation of dapagliflozin versus other glucose-lowering medications: a retrospective multicenter real-world study

6. Assessment of frailty as prognostic indicators in patients with septic shock

8. The association between clinical laboratory data and chest CT findings explains disease severity in a large Italian cohort of COVID-19 patients

9. Erratum: Correction to: Screening of postpartum diabetes in women with gestational diabetes: high‑risk subgroups and areas for improvements-the STRONG observational study (Acta diabetologica (2021) 58 9 (1187-1197))

10. The value of computed tomography in assessing the risk of death in COVID-19 patients presenting to the emergency room

11. HASH(0x563d4404f1c0)

12. Similar effectiveness of dapagliflozin and GLP-1 receptor agonists concerning combined endpoints in routine clinical practice: A multicentre retrospective study

15. Accuracy of CT in a cohort of symptomatic patients with suspected COVID-19 pneumonia during the outbreak peak in Italy

19. In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance

20. In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance

21. Comparative Effectiveness of DPP-4 Inhibitors Versus Sulfonylurea for the Treatment of Type 2 Diabetes in Routine Clinical Practice: A Retrospective Multicenter Real-World Study

23. Liraglutide and Renal Outcomes in Type 2 Diabetes

24. Knowledge transfer: What drug information would specialist doctors need to support their clinical practice? Results of a survey and of three focus groups in Italy

25. Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes): A multicenter retrospective nationwide Italian study and crowdsourcing opportunity

26. PHP306 - CAN GRADEPRO SUPPORT AND IMPROVE CHOICE OF OUTCOMES IN HEALTH TECHNOLOGY ASSESSMENT? REPORT ON A PILOT USE WITHIN THE EUNETHTA ASSESSMENT OF FEMTOSECOND LASER ASSISTED CATARACT SURGERY (FLACS)

27. Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes)

28. Metabolic syndrome in subjects at high risk for type 2 diabetes: The genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study

29. Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group

30. Assessment of the awareness and management of cardiovascular complications of acromegaly in Italy. The COM.E.T.A. (COMorbidities Evaluation and Treatment in Acromegaly) Study

31. Efficacy and tolerability of rosuvastatin and atorvastatin when force-titrated in patient with primary hypercholesterolemia: results from the ECLIPSE study

32. First-line therapy of acromegaly: A statement of the A.L.I.C.E. (Acromegaly primary medical treatment Learning and Improvement with Continuous Medical Education) Study Group

33. First-line therapy of acromegaly: a statement of the A.L.I.C.E. (Acromegaly primary medical treatment Learning and Improvement with Continuous Medical Educcation) Studi Group

35. Centella Asiatica and Lipoic Acid, or a combination thereof, inhibit monocyte adhesion to endothelial cells from umbilical cords of gestational diabetic women

36. Features of endothelial dysfunction in umbilical cord vessels of women with gestational diabetes

37. Identifying patients at risk for microalbuminuria via interaction of the components of the metabolic syndrome: a cross-sectional analytic study

38. Use of the Diabetes Risk Score for Opportunistic Screening of Undiagnosed Diabetes and Impaired Glucose Tolerance: The IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study

40. Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus.

41. Cell signalling

48. Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetic subjects.

Catalog

Books, media, physical & digital resources